Category: Finance
Multi-commodity potential: Miramar picks up a new copper and uranium play in WA
Miramar Resources applies for exploration licences over copper and uranium prospects in Gascoyne region of WA Prospects in same rocks as Yangibana and Yin REE [more…]
Market Highlights: Oil, travel stocks in focus as crude tumbles to 5-month low; and 5 ASX small caps to watch
ASX to open lower on Thursday, tracking Wall Street Travel, airlines and oil stocks in focus after oil drops to 5-month low China rejects Moody’s [more…]
Alicanto has a strong start to its new drilling campaign near its 1000-year-old Falun mine
Alicanto notes highly encouraging results: At Krondiket, strong proximal alteration has been intercepted with the potential for a new upflow zone immediately to the west [more…]
Critical Minerals are critical. And also minerals: Tru Datt!
Welcome to Tru Datt, a Stockhead exclusive featuring the insights and opportunities as per Emanuel Datt – founder and chief investment officer at Datt Capital [more…]
MoneyTalks: The Greatest Wealth is Health, says Morningstar’s Shane Ponraj and Virgil
MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right now. Today we hear [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Thursday, 7 December – a day on the calendar that sums up just how godawful the Roman Empire was [more…]
Canada Unearthed: How do the top TSX resources stocks of 2023 stack up against their ASX peers?
Like the ASX, the Canadian bourse has traditionally been a prolific breeding ground for exploration and mining stocks. Despite fears it is turning into a [more…]
A titan for women in resources: Leighton leads the way in Ecuador
With an interest in science and a love for the outdoors and “red dirt”, Melanie Leighton was always destined for a career in geology, even [more…]
The ASX stocks hoping to profit from the endless search for an ‘elixir of youth’
Anti-aging market is set for a CAGR of 5.5% over the next decade to reach US$109.8 billion in 2023 Bioxyne subsidiary Breathe Life Sciences develops [more…]
Skin in the game: Which directors are buying shares in their companies this week?
This past week has seen several directors of resources explorers and miners increase their stake in their companies, buying shares in on market trades or [more…]
